001     284347
005     20260129113850.0
024 7 _ |a 10.1021/jacs.5c19450
|2 doi
024 7 _ |a pmid:41552975
|2 pmid
024 7 _ |a 0002-7863
|2 ISSN
024 7 _ |a 1520-5126
|2 ISSN
024 7 _ |a 1943-2984
|2 ISSN
037 _ _ |a DZNE-2026-00118
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Weil, Tatjana
|b 0
245 _ _ |a Advanced Molecular Tweezers Effectively Target Membranes Lacking Choline Headgroups for Broad-Spectrum Antiviral Efficacy.
260 _ _ |a Washington, DC
|c 2026
|b ACS Publications
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1769682956_4636
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Broad-spectrum antivirals are urgently required to counter present and emerging viral threats. It has previously been shown that the parental molecular tweezers CLR01 and CLR05 disrupt viral envelopes by complexing choline headgroups and that ester-functionalized 'advanced' tweezers display markedly enhanced antiviral potency. Here, we determine the molecular basis of this improved activity. Using liposome leakage assays, giant unilamellar vesicles, NMR, Langmuir film balance experiments, and atomistic simulations, we demonstrate that advanced tweezers not only encapsulate choline-containing lipids but also engage lipids lacking choline headgroups via transient and conserved hydrophobic insertion events. These interactions preferentially destabilize membranes enriched in sphingomyelin, unsaturated acyl chains, or inverted cone-shaped lipids and are especially effective against small, highly curved particles resembling viral particles, explaining their broad antiviral activity for enveloped viruses. Our findings reveal a dual mechanism of action, choline binding and hydrophobic insertion, that underpins the broad-spectrum antiviral activity of advanced molecular tweezers and establish them as a promising new class of membrane-targeting antivirals for prophylactic and therapeutic use.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a Lawrenz, Jan
|0 0000-0003-3767-7130
|b 1
700 1 _ |a Taghuo Kaptouom, Estelle
|b 2
700 1 _ |a Mieres-Perez, Joel
|0 0000-0002-7875-0886
|b 3
700 1 _ |a Hunszinger, Victoria
|0 P:(DE-2719)9003513
|b 4
|u dzne
700 1 _ |a Sparrer, Konstantin M J
|0 P:(DE-2719)9003481
|b 5
700 1 _ |a Almeida-Hernandez, Yasser
|0 0000-0001-9832-3534
|b 6
700 1 _ |a Schrader, Thomas
|0 0000-0002-7003-6362
|b 7
700 1 _ |a Sanchez-Garcia, Elsa
|0 0000-0002-9211-5803
|b 8
700 1 _ |a Münch, Jan
|0 0000-0001-7316-7141
|b 9
773 _ _ |a 10.1021/jacs.5c19450
|g Vol. 148, no. 3, p. 3626 - 3637
|0 PERI:(DE-600)1472210-0
|n 3
|p 3626 - 3637
|t Journal of the American Chemical Society
|v 148
|y 2026
|x 0002-7863
856 4 _ |u https://pub.dzne.de/record/284347/files/DZNE-2026-00118_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/284347/files/DZNE-2026-00118_SUPP.pdf
856 4 _ |u https://pub.dzne.de/record/284347/files/DZNE-2026-00118_Restricted.pdf?subformat=pdfa
|x pdfa
856 4 _ |u https://pub.dzne.de/record/284347/files/DZNE-2026-00118_SUPP.pdf?subformat=pdfa
|x pdfa
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 4
|6 P:(DE-2719)9003513
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9003481
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM CHEM SOC : 2022
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-13
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1210
|2 StatID
|b Index Chemicus
|d 2024-12-13
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b J AM CHEM SOC : 2022
|d 2024-12-13
920 1 _ |0 I:(DE-2719)1910003
|k AG Sparrer
|l Neurovirology and Neuroinflammation
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1910003
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21